Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2021 Feb 26;87(6):e02957-20. doi: 10.1128/AEM.02957-20

Generation of Lactose- and Protease-Positive Probiotic Lacticaseibacillus rhamnosus GG by Conjugation with Lactococcus lactis NCDO 712

Nazar Hussain a,b,c,#, Ran Li c,✉,#, Timo M Takala c, Muhammad Tariq a,b, Arsalan H Zaidi a,b, Per E J Saris c,
Editor: Danilo Ercolinid
PMCID: PMC8105022  PMID: 33419737

Probiotic strain Lacticaseibacillus rhamnosus GG (LGG) is widely sold on the market as a probiotic or added as a supplement in dairy foods because of its benefits in human health. However, due to the deficiency of lactose and casein utilization, LGG does not grow well in milk.

KEYWORDS: Lacticaseibacillus rhamnosus GG, lactose, protease, conjugation, probiotic

ABSTRACT

Lacticaseibacillus rhamnosus GG (LGG) is the most studied probiotic bacterium in the world. It is used as a probiotic supplement in many foods, including various dairy products. However, LGG grows poorly in milk, as it neither metabolizes the main milk carbohydrate lactose nor degrades the major milk protein casein effectively. In this study, we made L. rhamnosus GG lactose and protease positive by conjugation with the dairy Lactococcus lactis strain NCDO 712 carrying the lactose-protease plasmid pLP712. A lactose-hydrolyzing transconjugant colony was obtained on agar containing lactose as the sole source of carbohydrates. By microscopic analysis and PCR with LGG- and pLP712-specific primers, the transconjugant was confirmed to have originated from LGG and to carry the plasmid pLP712. The transconjugant was named L. rhamnosus LAB49. The isolation of plasmids revealed that not only pLP712 but also other plasmids had been transferred from L. lactis into LGG during conjugation. With plasmid-specific PCR primers, four additional lactococcal plasmids were detected in LAB49. Proteolytic activity assay and SDS-PAGE analysis verified that L. rhamnosus LAB49 effectively degraded β-casein. In contrast to its parental strain, LGG, the ability of LAB49 to metabolize lactose and degrade casein enabled strong and fast growth in milk. As strains with new properties made by conjugation are not regarded as genetically modified organisms (GMOs), L. rhamnosus LAB49 could be beneficial in dairy fermentations as a probiotic starter culture.

IMPORTANCE Probiotic strain Lacticaseibacillus rhamnosus GG (LGG) is widely sold on the market as a probiotic or added as a supplement in dairy foods because of its benefits in human health. However, due to the deficiency of lactose and casein utilization, LGG does not grow well in milk. On the other hand, lactose intolerance and cow’s milk protein allergy are the two major problems related to milk consumption. One option to help with these two conditions is the use of probiotic or lactose- and casein-hydrolyzing bacteria in dairy products. The purpose of this study was to equip LGG with lactose/casein-hydrolyzing ability by bacterial conjugation. As a result, we generated a non-GMO LGG derivative with improved properties and better growth in milk.

INTRODUCTION

Lacticaseibacillus rhamnosus GG (LGG; ATCC 53103) is a well-characterized probiotic strain widely used in various foods (1, 2). LGG was originally isolated from feces of healthy human (3), and over the last 3 decades, it has been extensively studied for its probiotic properties and impact on human health (4, 5). The strain has strong adhesion ability to the intestinal mucosa, and it has been used for the prevention and treatment of diarrhea and gastrointestinal infections and to boost host immune responses against allergic reactions (6). LGG is documented to maintain a good microbial balance of bacteria in the human gut by preventing the growth of harmful bacteria (7).

Lactococcus lactis subsp. cremoris NCDO 712 is a dairy strain originally isolated from cheese starter culture. The strain carries six plasmids, namely, pSH71 (2.1 kb), pSH72 (3.6 kb), pSH73 (8.7 kb), pSH74 (15.5 kb), pNZ712 (49.8 kb), and pLP712 (55.4 kb) (8). Plasmid pLP712 provides L. lactis NCDO 712 the ability to grow in milk, as it contains the gene encoding the serine protease PrtP for casein degradation as well as the genes for lactose catabolism (Fig. 1) (9, 10).

FIG 1.

FIG 1

Plasmid pLP712. Genes relevant to this study are shown as arrows with different colors: lactose genes lacR and lacABCDFEGX are marked in green, protease and maturation genes prtP and prtM are marked in blue, replication and plasmid partitioning genes repA, repC, and parAB are marked in red, and transposases are marked in gray. Other open reading frames are marked as empty arrows with locus numbers or known gene abbreviations. The plasmid map was created by SnapGene (Insightful Science; GSL Biotech LLC, San Diego, CA, USA), and the sequence was extracted from the NCBI GenBank database (accession number FJ649478) (10).

Bovine milk contains about 4.8% lactose, while human milk contains up to 7% lactose (11). Lactose is an important energy source for breast-fed human infants, constituting around 40% of the total daily energy intake (12). After weaning, around 70% of the world population experiences a decline in lactose-hydrolyzing enzyme activity in small intestine due to genetic factors, leading to lactose intolerance (1315). Besides lactose intolerance, cow’s milk protein allergy (CMPA) is a common food allergy with an estimated prevalence of 2 to 3% worldwide (16). One option to reduce the symptoms of lactose intolerance and CMPA is the use of probiotic or lactose- and/or casein-hydrolyzing bacteria in dairy products (11, 17). These bacteria increase the overall hydrolytic capacity of the small intestine that promotes lactose digestion (18). In addition, bacteria in fermented products can decrease the lactose concentration and increase active lactase enzyme entering the intestine (19). LGG is used as a probiotic supplement in various dairy products, such as fermented and pasteurized milk, cheese, and yogurt. However, LGG does not grow well in milk (20, 21) due to the lack of its capacity to hydrolyze lactose and casein, the main nutrients in milk (2224). The inability to grow in milk limits the possible uses of LGG as a starter strain.

The properties of probiotics can be modified and improved by genetic engineering. LGG has been made lactose positive by fixing the two mutations in its lactose operon (25). Even though the resulting lactose-hydrolyzing LGG did not carry foreign genetic material, the strain is regarded as a genetically modified organism (GMO) in the EU, because it was made by using recombinant DNA techniques. The EU legislation considers relevant “the way” the modification was performed. Use of GMOs in food is heavily regulated and not popular among consumers in the EU (2628). Therefore, modifications and improvements of food bacteria should be performed by non-GMO transformation methods, which include, e.g., transduction and conjugation of natural phages, plasmids, or transposons (28). Regarding lactic acid bacteria, the lactose-protease plasmid pLP712 in L. lactis NCDO 712 has been transferred into lactose-deficient strains by conjugation (29). Even though conjugation can occur between different bacterial species and even between different genera, pLP712 has only been transferred within the species L. lactis. Regarding LGG, the only published study about conjugation is the unsuccessful transfer of vancomycin resistance between LGG and enterococci (30). There are no reports about effective conjugation in LGG.

In this study, we generated a proteolytic and lactose-positive LGG strain by conjugation of the lactose-protease plasmid pLP712 from L. lactis. The resulting transconjugant strain L. rhamnosus LAB49 effectively hydrolyzed lactose and β-casein, and it grew well in milk. Hence, L. rhamnosus LAB49 can be regarded as an upgraded food-grade and non-GMO derivative of LGG.

RESULTS

Conjugation of pLP712 into L. rhamnosus GG.

Lacticaseibacillus rhamnosus GG is a lactose-negative strain. The first aim in this work was to make it lactose positive by conjugal transfer of the lactose-protease plasmid pLP712 from Lactococcus lactis NCDO 712. As LGG is endogenously resistant to vancomycin whereas NCDO 712 is sensitive, transconjugants were selected on agar plates containing vancomycin and lactose as selective agents, supplemented with BCP, indicating acid production from lactose. Approximately 15 vancomycin-resistant, lactose-hydrolyzing yellow colonies appeared on each selective agar plate, giving a transfer frequency of approximately 4 × 10−8 progeny per recipient. One colony was chosen for closer analyses. By phase-contrast microscopy, it was seen that the chosen strain was a rod-shaped bacterium forming long chains typical of L. rhamnosus GG. The strain was streaked on a selective agar plate to confirm its lactose utilization capacity (Fig. 2). Wild-type LGG did not change the purple color of the agar by acid production due to the lack of lactose-digesting ability. The transconjugant changed the color from purple to yellow due to lactic acid production by lactose fermentation. The putative transconjugant was named L. rhamnosus LAB49.

FIG 2.

FIG 2

Growth of LGG and LAB49 on mMRS-lactose-BCP plates. LGG, L. rhamnosus GG with no acid production and color change. LAB49, the transconjugant L. rhamnosus LAB49 has produced acid from lactose, causing color change from purple to yellow.

Molecular techniques were applied to confirm that LAB49 was a derivative of L. rhamnosus GG and that it contained pLP712. Two pairs of previously published strain-specific PCR primers for identifying LGG were used. Both primer pairs gave amplifications of expected sizes (801 bp and 757 bp) from LGG and the transconjugant but not from L. lactis (Fig. 3). The presence of the lactose-protease plasmid pLP712 in LAB49 was then examined with lactococcal prtP-specific primers. Correct 2.5-kb bands were amplified from LAB49 and L. lactis NCDO 712 but not from LGG (Fig. 3). These results confirmed that the transconjugant undoubtedly originated from LGG and that the plasmid pLP712 had successfully been conjugated from its native carrier, L. lactis NCDO 712, into LGG.

FIG 3.

FIG 3

Verification of L. rhamnosus LAB49 as a derivative of L. rhamnosus GG and the presence of pLP712 in LAB49 by PCR with spaC-, LGG-, and pLP712-specific primers. Lanes 1, 4, and 7, L. rhamnosus LAB49; lanes 2, 5, and 8, L. rhamnosus GG; lanes 3, 6, and 9, L. lactis NCDO 712. Lanes 1 to 3, LGG-specific spaC primers amplifying 801-bp PCR product; lanes 4 to 6, LGG-specific primers amplifying 757-bp PCR product; lanes 7 to 9, pLP712-specific primers amplifying 2.5-kb fragment of L. lactis prtP gene. M1, 100-bp GeneRuler DNA ladder. M2, 1-kb GeneRuler DNA ladder.

Identification of plasmids in L. rhamnosus LAB49.

To visualize the plasmid pLP712 in the transconjugant, plasmids of L. rhamnosus LAB49 were isolated and compared to the plasmid profiles of LGG and L. lactis NCDO 712. In the results of plasmid electrophoresis, there were no plasmid bands from the wild-type LGG, as anticipated, and only one band representing the chromosomal DNA could be seen in gel (Fig. 4, lane 3). As also expected based on previous studies (9), plasmid isolation from NCDO 712 resulted in several plasmid bands of different sizes, representing the six plasmids of the strain (Fig. 4, lane 2). Interestingly, the transconjugant strain LAB49 also carried many plasmids, obviously both large and small, as many bands were seen in plasmid gel (Fig. 4, lane 1). Apparently, conjugation of pLP712 had mobilized other plasmids, which were cotransferred to L. rhamnosus GG without any selection pressure. To identify which plasmids had been transferred, PCR with plasmid-specific primers was conducted. Four additional lactococcal plasmids were found and identified to be pSH71 (2,062 bp), pSH72 (3,597 bp), pSH73 (8,663 bp), and pNZ712 (49.83 kb) (Fig. 5). Hence, of all six plasmids present in NCDO 712, five were transferred by conjugation, and only the plasmid pSH74 (15.52 kb) could not be detected in LAB49.

FIG 4.

FIG 4

Plasmid profiles of L. rhamnosus LAB49, L. lactis NCDO 712, and L. rhamnosus GG. Lanes: 1, L. rhamnosus LAB49; 2, L. lactis NCDO 712; 3, L. rhamnosus GG. Chr, chromosomal DNA band. LAB49 and NCDO 712 carry several plasmids, whereas no plasmids can be seen in L. rhamnosus GG. M, 1-kb GeneRuler DNA ladder.

FIG 5.

FIG 5

Identification of plasmids by PCR from isolated DNA of L. rhamnosus LAB49, L. lactis NCDO 712, and L. rhamnosus GG. Lanes 1, 4, 7, 10, and 13, L. rhamnosus LAB49 as the PCR template; lanes 2, 5, 8, 11, and 14, L. lactis NCDO 712 as the PCR template; lanes 3, 6, 9, 12, and 15, L. rhamnosus GG as the PCR template. Plasmid-specific primers were used to identify pSH71 (lanes 1 to 3), pSH72 (lanes 4 to 6), pSH73 (lanes 7 to 9), pNZ712 (lanes 10 to 12), and pSH74 (lanes 13 to 15). All plasmids were detected in NCDO 712, whereas pSH74 was missing from LAB49. No plasmids were detected in LGG. M1, 1-kb GeneRuler DNA ladder. M2, 100-bp GeneRuler DNA ladder.

Stability of the plasmid pLP712 in LAB49.

The stability of pLP712 in L. rhamnosus LAB49 under nonselective conditions was determined. LAB49 was grown in de Man, Rogosa, Sharpe (MRS) broth containing 2% glucose for about 100 generations, and lactose utilization was tested at about every 10 generations. After 90 generations, only 2% of the cells retained the lactose-fermenting ability, and after 100 generations all tested colonies (n = 80) were lactose negative (Fig. 6A). The results indicated that the plasmid pLP712 is either easily lost in L. rhamnosus LAB49 without selection pressure by lactose or easily makes rearrangements causing mutations or deletion of lactose genes. To verify this, 20 lactose-negative colonies were examined for protease activity on 2% milk agar. All the tested colonies showed clear proteolytic activity, indicating that the LAB49 cells still carried the gene prtP and, hence, the plasmid pLP712, but the lactose genes in the plasmid had been mutated or deleted (Fig. 6B).

FIG 6.

FIG 6

(A) Percentage of lactose-positive L. rhamnosus LAB49 colonies as a function of generations grown under nonselective conditions. LAB49 was cultured in MRS without lactose for 100 generations. Every 10 generations, colonies were tested for lactose utilization. LAB49 completely loses the capacity to ferment lactose in 100 generations under nonselective conditions. (B) Protease activity test for the lactose-negative LAB49 colonies. Sections 1 to 5, lactose-negative L. rhamnosus LAB49 grown for 100 generations in nonselective media; 712, L. lactis NCDO712; 49, L. rhamnosus LAB49; LGG, L. rhamnosus GG. The clear zone around spotted bacteria demonstrates proteolytic activity. The protease-positive but lactose-negative phenotype of LAB49 indicates that the plasmid pLP712 is still present in the cells and that pLP712 is segregationally stable but structurally unstable.

Proteolytic activity.

As L. rhamnosus GG does not effectively degrade β-casein, we tested whether the lactococcal PrtP protease encoded by the gene prtP in the plasmid pLP712 would make LGG proteolytically more active. To test the phenotype, proteolytic activity assay was performed for the digestion of β-casein. Protease production was first induced on milk citrate agar, after which the cells were incubated with β-casein. SDS-PAGE analysis confirmed that β-casein was fully digested in 4 h by LAB49 and NCDO 712 but not at all by LGG (Fig. 7). When the protease inhibitor phenylmethylsulfonyl fluoride (PMSF) was added to the cell-casein mixture, β-casein was not degraded by any strain, even after 16 h of incubation. This verified that the observed casein degradation was indeed a result of protease activity, obviously by the lactococcal protease PrtP. In conclusion, the ability of L. rhamnosus LAB49 to hydrolyze casein showed that the plasmid conjugation had made the strain proteolytic and that LAB49 could degrade proteins in milk, thereby improving its growth.

FIG 7.

FIG 7

Proteolytic activity assay (β-casein degradation). Lanes 1, 2, and 3, β-casein incubated with L. lactis NCDO 712, L. rhamnosus LAB49, and L. rhamnosus GG, respectively; lane 4, β-casein without bacterial incubation; lanes 5, 6, and 7, β-casein and PMSF incubated with L. lactis NCDO 712, L. rhamnosus LAB49, and L. rhamnosus GG, respectively; M, protein ladder, mid-range molecular weight (10 to 180 kDa).

Growth in milk.

Next, as LAB49 utilized lactose and casein, we wanted to determine whether these properties improve growth in milk compared to that of LGG. As shown in Fig. 8, the transconjugant L. rhamnosus LAB49 grew well in milk, reaching stationary phase (approximately 109 CFU/ml) in 11 to 12 h after inoculation. Its strongest exponential growth phase took place about 2 to 4 h after inoculation, and a generation time calculated at that 2-h time period was about 40 min. During the first 4-h time period from the inoculation, there were 4.6 generations, giving a single-generation time of 52 min. As expected, the parental strain LGG could not properly grow in milk; thus, its generation time was not calculated. The apparent coagulation of milk with LAB49 started a few hours after inoculation, and the milk was fully coagulated after 12 h of incubation. In contrast, LGG-milk was still liquid after 24 h at 37°C (results not shown). To sum up, the new abilities to metabolize lactose and degrade casein enabled good growth of LAB49 in milk.

FIG 8.

FIG 8

Growth of L. rhamnosus LAB49 and LGG in milk. LAB49 grows well and reaches stationary phase in about 12 h. The growth of LGG is poor. Error bars show standard deviations of the means from three parallel cultures.

DISCUSSION

Lactose and casein are the main nutrients in milk. The most studied probiotic lactic acid bacterium in the world, L. rhamnosus GG, grows poorly in milk, as it is not able to hydrolyze lactose or casein. In this study, we have given LGG the ability to thrive in milk by transferring the lactose-protease plasmid pLP712 from L. lactis NCDO 712 via conjugation. With the aid of pLP712, the LGG transconjugant strain LAB49 could hydrolyze both lactose and casein; thus, the transconjugant grew considerably better in milk than the parental LGG.

The plasmid pLP712 earlier had been transferred by conjugation only into other strains of L. lactis (31, 32). Here, we present the intergeneric conjugation of pLP712. Transfer frequency (4 × 10−8 progeny per recipient) from L. lactis to L. rhamnosus was somewhat lower than what has been described with conjugation of pLP712 between L. lactis strains (about 10−7 progeny per recipient) (9, 33). Successful conjugation of LGG has not been reported before, as the only published trial was the unsuccessful transfer of vancomycin resistance from LGG to Enterococcus (30). This result cannot be regarded as a disappointment, as it emphasizes the safety of LGG. Vancomycin resistance in LGG is a chromosomally encoded property; thus, it is not easily transferred horizontally. However, mobile DNA elements, such as conjugative plasmids, may also mobilize chromosomal genes (34). Consequently, it is possible that the plasmids in LAB49 mobilize the chromosomal d-alanine-d-alanine ligase gene ddlA, presumably behind the intrinsic vancomycin resistance. Still, most, if not all, of the naturally vancomycin-resistant lactobacilli carry endogenous mobile DNA elements, transposases, insertion sequences, and conjugative plasmids (35). Even though it has been suggested that probiotics spread vancomycin resistance (36), their mobile DNA elements have not been shown to trigger mobilization of the ddlA gene and transfer vancomycin resistance; thus, such an incident could be considered unlikely.

Instead, properties encoded by plasmids, including those in nonconjugative plasmids, are much more likely to be transferred. In our work here, three nonconjugative plasmids, namely, pSH71, pSH72, and pSH73, were mobilized with the conjugative plasmids pLP712 and pNZ712. Transfer of pNZ712, however, also can be considered coconjugation, as there was no selection pressure for its transfer. Nonconjugative plasmids without selection pressure for their transfer have been shown to cotransfer easily with conjugative plasmids. For instance, in the study by Barry et al. (32), nonconjugative plasmids were transferred along with the conjugative ones in all 143 conjugation trials made. Thus, mobilization of nontransmissible plasmids seems to be a common phenomenon. Interestingly, the only plasmid not transferred from L. lactis NCDO 712 into LGG was pSH74 carrying the spa genes for a pilus structure (8). Both NCDO 712 and LGG carry similar pili (37). Even though it has been shown that the NCDO 712 pilus contributes to conjugation efficiency, its precise function in DNA exchange is not known. Regarding LGG, its pili are associated with its probiotic nature, e.g., adhesive interactions with intestinal epithelial cells (38). The fact that the conjugated plasmids have provided several new features to LAB49 compared to LGG may raise a concern about the probiotic capacity of LAB49. Hence, it would be good to investigate whether LAB49 still holds the probiotic activity of LGG, e.g., the adherence to epithelial cells.

Many studies have reported the structural instability of the plasmid pLP712, particularly occurring during conjugation (10, 39). The deletions and DNA rearrangements in pLP712 seem to happen spontaneously, often resulting in lactose- or protease-deficient transconjugants. Apparently, the deletions are caused by the numerous insertion sequence elements and transposase genes present in the plasmid (Fig. 1). Different ways for lactose gene deletions by transposases in pLP712 have been described previously (10). Despite the recognized structural instability, pLP712 has been reported to be segregationally stable in L. lactis. As shown in the study by O’Sullivan et al. (31), after 75 generations in nonselective medium, no loss of pLP712 was observed in L. lactis transconjugant, as confirmed by plasmid isolations. In the present study, the lactose metabolism of the transconjugant LAB49 was stable when the strain was grown with lactose, but without the selection pressure by lactose, the capacity to utilize lactose was completely gone in about 100 generations. However, when examining the proteolytic activity of the lactose-negative colonies after 100 generations under nonselective conditions, we found that all of them exhibited protease activity, indicating the presence of pLP712. The proteolytic halo observed in Fig. 6B showed that the loss of lactose metabolism was not caused by plasmid disappearance; rather, the plasmid underwent structural changes resulting in mutations or deletion of lactose genes, possibly in the way shown by Wegmann et al. (10). Hence, our results confirmed the previous findings that pLP712 is segregationally stable but structurally unstable. Nevertheless, as long as the strain is cultured with lactose, the selection pressure will ensure that the lactose genes are functional.

For an unknown reason, LGG does not hydrolyze casein, which affects its growth in milk (37). The casein deficiency of LGG has been proposed to be caused by the lack of the gene LC705_02680 encoding a subtilisin-like serine protease containing an LPXTG motif, present in the proteolytic L. rhamnosus strain LC705 (37). However, LGG carries intact prtP and prtM genes encoding subtilisin-like cell envelope serine protease and its maturation protein, respectively. The proteins are identical (99% identity) to those of L. rhamnosus LC705 but only 74 to 78% identical to those encoded by pLP712. Thus, PrtP may be the responsible enzyme for casein degradation in L. Lactis but not in L. rhamnosus, and in the latter the additional protease encoded by the gene LC705_02680 is needed for casein hydrolysis. On the other hand, it is not known whether prtP or prtM is expressed in LGG. A possible reason for LGG’s inability to degrade casein can be a fatal mutation in the intergenic prt promoter region. The prt promoters in L. lactis and L. rhamnosus LC705 have been shown to be inducible in media with low peptide concentrations and rich in partially hydrolyzed casein (37, 40). The DNA sequences of the prtMP genes in LC705 and LGG are 98% identical, whereas the intergenic 284/285-bp regulatory region is less identical, differing by 16 bp (94% identical). This suggests that the prt promoters in LGG have mutated and are not fully functional. It would require further studies to confirm whether the casein deficiency of LGG is due to the lack of additional protease or a mutation in the promoter region. Nevertheless, as shown in this study, heterologous lactococcal PrtP, produced in LGG, restores its casein-hydrolyzing phenotype.

LGG carries the genes lacTEGF for the lactose phosphotransferase system (37). Two mutations in the Lac-PTS operon make LGG lactose deficient: a nonsense mutation in the phospho-β-galactosidase gene lacG and a 4-bp deletion creating a frameshift in the antiterminator gene lacT. These mutations have been fixed by spontaneous mutagenesis with the help of a lacT expression plasmid, resulting in lactose-positive LGG (25). Because the strain was created by using a recombinant plasmid, even though absent in the resulting strain, it is regarded as a GMO in the EU; thus, its use in food is strongly regulated and restricted as well as widely disliked by consumers (26, 27). On the contrary, the lactose-positive LGG generated in our work here is not regarded as a GMO in the EU, because conjugation is an accepted non-GMO method for bacterial strain modifications (28). This is because conjugation is not a recombinant DNA technique; rather, it happens in nature between bacteria (41). Of course, to be regarded as a safe genetic modification, the DNA to be conjugated must be endogenous DNA from food-grade bacteria, and it should not carry antibiotic resistance genes (42). All six plasmids in L. lactis NCDO 712 fulfill these criteria.

L. rhamnosus LAB49 grew well in milk and also coagulated milk thoroughly, apparently due to proteolytic digestion of casein and lactic acid production from lactose. The growth of LAB49 in milk was also expressed as generation time, calculated to be about 40 min at its lowest in early log phase and 52 min during the first 4-h period. The similar generation time of LGG was previously determined in MRS (3), being 45 min during the first 4 h after inoculation. In this work, it was not meaningful to calculate generation time for LGG, as it did not grow properly in milk.

The phenotype of L. rhamnosus LAB49 showed that the properties of probiotic L. rhamnosus GG can be modified by conjugation, as the transconjugant L. rhamnosus LAB49 could utilize lactose, degrade casein, and grow better in milk than the parental strain. Therefore, compared to LGG, L. rhamnosus LAB49 has new possibilities in dairy applications, for instance, in helping with the symptoms of lactose intolerance or CMPA. Probiotics, particularly lactobacilli and bifidobacteria, have been used for the prevention or treatment of CMPA among infants. The use of wild-type L. rhamnosus GG for CMPA in animal models has provided positive effects and alleviated allergic reactions (43, 44). As shown in this paper, LAB49 hydrolyzes casein; thus, it would be interesting to investigate the efficacy of L. rhamnosus LAB49 in reducing the symptoms of CMPA.

MATERIALS AND METHODS

Bacterial strains and growth media.

Lactococcus lactis subsp. cremoris strain NCDO 712 carrying the lactose-protease plasmid pLP712 (Fig. 1) (9) was used as the plasmid donor strain, and the lactose-negative Lacticaseibacillus rhamnosus strain GG (LGG; ATCC 53103) (3) was used as the recipient strain in mating experiments. LGG was routinely cultured in de Man, Rogosa, Sharpe (MRS; Merck, Darmstadt, Germany) medium at 37°C. L. lactis NCDO 712 (9) was grown at 30°C in M17 medium supplemented with 0.5% (wt/vol) glucose.

Conjugation.

L. lactis NCDO 712 and LGG were mated for the transfer of the conjugative plasmid pLP712. Prior to conjugation, both strains were grown in their respective medium overnight. From each culture, 1.5 ml was centrifuged (4,300 × g), and the cells were washed with 1.5 ml of 0.85% NaCl and resuspended in 1.5 ml MRS broth. Donor NCDO 712 (75 μl) and recipient LGG (750 μl) suspensions were added into 3 ml MRS broth. The mixture was incubated for 4 h at 37°C, and then 200 μl of broth was spread in triplicate onto transconjugant selective agar made of modified MRS (mMRS; MRS without glucose and meat extract) supplemented with 1% lactose, 100 μg/ml vancomycin, and 50 μg/ml bromocresol purple (BCP). Vancomycin prevents the growth of Lactococcus, whereas LGG does not utilize lactose. The fermenting of lactose produces lactic acid, which lowers the pH of the media and, thus, changes the color of BCP from purple to yellow. The plates were incubated for 24 to 48 h at 37°C in an anaerobic jar. Obtained colonies were streaked onto new selective agar plates to obtain pure cultures and further cultured and maintained in mMRS broth medium with 1% lactose. The transconjugant strain was preserved in respective medium containing 20% (vol/vol) glycerol and stored in cryovials at −80°C.

Confirmation of conjugation: strain and plasmid-specific PCR analysis.

The transconjugant strain was confirmed by colony PCR using primers specific to L. rhamnosus GG (45, 46) or pLP712 (Table 1). The LGG-specific spaC primers amplify an 801-bp fragment from the pilus gene spaC. The other LGG-specific primer pair (A and B) amplifies a 757-bp fragment containing the hypothetical conserved protein gene LGG_00154. Phusion high-fidelity DNA polymerase (Thermo Fisher Scientific, Waltham, MA, USA) was used for PCR amplification. The reaction mixture (25 μl) contained 20 pmol each primer, Phusion HF buffer, 0.2 mM deoxynucleotide triphosphates, 0.5 U Phusion DNA polymerase, and cells from a single colony as the template. PCR amplifications were performed in an Eppendorf Mastercycler (Hamburg, Germany) using the following thermal cycling profile: initial denaturation at 98°C for 30 s, 35 cycles of 98°C for 10 s, 60°C for 30 s, and 72°C for either 30 s (LGG specific PCR) or 60 s (pLP712 specific PCR), and a final extension step of 72°C for 5 min. PCR products (5 μl) were separated by electrophoresis in 1% (wt/vol) agarose gel containing 0.5 μg/ml ethidium bromide, and the DNA was visualized by a ChemiDoc MP imaging system (Bio-Rad, Hercules, CA, USA). The size markers used were 100-bp and 1-kb GeneRuler DNA ladders (Thermo Fisher Scientific).

TABLE 1.

PCR primers used in this study

Primer Sequence, 5′ to 3′ Reference or source Size (bp) Use
spaC-FW CCAAATTGGCAACAGACCTT 45 801  LGG specific
spaC-RV GCCATCTGGTGCTTTTGTTT
GG-spec-A CGCCCTTAACAGCAGTCTTC 46 757  LGG specific
GG-spec-B GCCCTCCGTATGCTTAAACC
prtP-FW CTCGAGGCTAGCTCGTTTGATTTAATTGTG This study 2,550  pLP712 specific
prtP-RV CCAGAATTCGGGCCCTATTCTTCACGTTGTTTCCG
repAC-FW CGTTTCTGAGACGTTTTAGCG This study 1,680  pSH71 specific
repAC-RV AAATAAAAGCCCCCTTCGACT
pSH72-FW GCTTTTTCGTTGGTTTGCTC 8 466  pSH72 specific
pSH72-RV GCCCAAAATAGTGGGTTAGTG
pSH73-FW TTTCAGTAGAAGGCCAAACAAC 8 803  pSH73 specific
pSH73-RV TGCAAATTTATCTACAAAGGCTTG
pSH74-newFW GTGGATGAACAAACAAAATACG This study 195  pSH74 specific
pSH74-newRV GGATTGTGTCGATTTGCTTTACGC
pNZ712-FW CACTCTAGTTTCCTACCTTCGTTGCAAGC 8 1,120  pNZ712 specific
pNZ712-RV GCTATACTTATACGGAGGATTAGCACTGG

Plasmid analyses and identifications.

Plasmid DNA was isolated from Lacticaseibacillus strains according to the method of Anderson and McKay (47), with modifications described by Wan et al. (48). Isolated DNA was run in agarose gel to analyze the plasmid profile. The size marker used was a 1-kb GeneRuler DNA ladder (Thermo Fisher Scientific). PCR primers specific to different L. lactis NCDO 712 plasmids were used to identify the conjugated plasmids (Table 1). The primer sequences were obtained from the study by Tarazanova et al. (8). As the PCR with the published primers to detect pSH74 did not work, new pSH74-specific primers were designed. PCR conditions and cycles were the same as those described above; the extension time at 72°C was 1 min for amplicons from plasmids pNZ712 and pSH71 (primers repAC-FW/RV), 30 s for pSH72 and pSH73, and 20 s for pSH74.

Plasmid stability.

To evaluate the segregational stability of pLP712 in L. rhamnosus LAB49 without selection pressure by lactose, fresh culture was sequentially inoculated in MRS broth at 0.1% inoculum and incubated at 37°C for 16 h. After every passage, up to 10 passages (approximately 100 generations) in the absence of lactose, the cultures were serially diluted and plated onto MRS agar. The next day, on average 80 single colonies were randomly picked and transferred onto mMRS-lactose-BCP agar plates and checked for their lactose fermentation ability after incubation for 24 h at 37°C.

Protease activity assays.

Proteolytic activity was determined by using two different assays. Lactose-negative LAB49 colonies from the plasmid stability test were examined for protease activity by an agar halo method based on van den Berg et al. (49). First, white Lac colonies from mMRS-lactose-BCP plates were transferred into MRS broth and incubated overnight at 37°C. Three-microliter aliquots of the cultures were spotted on the indicator agar made of mMRS without triammonium citrate but supplemented with 2% skim milk. The indicator plates were incubated at 37°C for 24 h. Hydrolysis of milk casein can be seen as a clear halo around the bacterial spot.

To show the actual casein degradation, another protease activity assay was performed according to the method described by Vukotic et al., with slight modifications (50). Protease production was induced by culturing the cells on milk citrate agar plates (containing 4.4% reconstituted milk, 0.1% yeast extract, 0.8% sodium citrate, 0.5% glucose, and 1.5% [wt/vol] agar) for 48 h at 30°C. The cells were resuspended in 0.1 M sodium phosphate buffer (pH 7.0) and adjusted to approximately 109 CFU/ml. β-Casein (∼24 kDa) (Sigma-Aldrich, St. Louis, MO, USA) solution (5 mg/ml) was prepared by dissolving in the same buffer. The cell suspension was mixed with β-casein solution at a ratio of 1:1 (vol/vol) and incubated for 4 h at 30°C, after which the cells were removed by centrifugation at 13,000 × g for 10 min. Clear supernatant was used for SDS-PAGE analysis. The supernatant was mixed with sample loading buffer (125 mM Tris-HCl, pH 6.8, 4% SDS, 0.01 mM EDTA, 5% 2-mercaptoethanol, 25% glycerol, and 0.07% bromophenol blue) at a ratio of 1:1 (vol/vol) and heated at 100°C for 5 min. Heated samples were loaded at 10 μl/well, and the gel (15%) was run for 20 h at 20 mA. The same concentration of β-casein solution without cell treatment was used as a reference to compare the bands. To confirm that β-casein was degraded by the activity of a protease, phenylmethylsulfonyl fluoride (PMSF), a protease inhibitor (2 mM), was added in β-casein solution and cell suspension mixture before overnight incubation in a separate experiment.

Growth in milk.

To perceive the difference between the growth of the two strains in milk, LAB49 and LGG were precultured for 20 h in milk (4.8% lactose; Valio Ltd., Helsinki, Finland) or milk with 2% glucose, respectively. After that, 10 ml of milk was seeded (1.5% inoculum) with the precultures. Inoculated milk samples were incubated at 37°C for 24 h, during which samples were taken every hour from 1 to 12 h and at 14, 16, 18, 20, 22, and 24 h to determine the number of CFU per milliliter by plate counting. Growth rate was expressed as generation time (GT), which was derived by using the equation GT = t/n, where t is the time interval in minutes and n is the number of generations, calculated with the formula n = (logb – logB)/log2, where B is the number of bacteria at the beginning of the time interval and b is the number of bacteria at the end of the time interval (51). Milk coagulation was observed visually. Sterilized milk without bacterial inocula was used as a negative control.

ACKNOWLEDGMENT

Ran Li is the recipient of a CSC fellowship (China Scholarship Council; grant no. 201706910094).

REFERENCES

  • 1.Doron S, Snydman DR, Gorbach SL. 2005. Lactobacillus GG: bacteriology and clinical applications. Gastroenterol Clin North Am 34:483–498. doi: 10.1016/j.gtc.2005.05.011. [DOI] [PubMed] [Google Scholar]
  • 2.Silva M, Jacobus N, Deneke C, Gorbach S. 1987. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 31:1231–1233. doi: 10.1128/aac.31.8.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gorbach SL, Goldin BR. June 1989. Lactobacillus strains and methods of selection. US patent 4839281A.
  • 4.Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. 2003. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361:1869–1871. doi: 10.1016/S0140-6736(03)13490-3. [DOI] [PubMed] [Google Scholar]
  • 5.Szajewska H, Mrukowicz JZ. 2001. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastr Nutr 33:S17–S25. doi: 10.1097/00005176-200110002-00004. [DOI] [PubMed] [Google Scholar]
  • 6.Segers ME, Lebeer S. 2014. Towards a better understanding of Lactobacillus rhamnosus GG-host interactions. Microb Cell Fact 13:S7–S16. doi: 10.1186/1475-2859-13-S1-S7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lee YK, Salminen S. 2009. Handbook of probiotics and prebiotics. John Wiley & Sons, Hoboken, NJ. [Google Scholar]
  • 8.Tarazanova M, Beerthuyzen M, Siezen R, Fernandez-Gutierrez MM, de Jong A, van der Meulen S, Kok J, Bachmann H. 2016. Plasmid complement of Lactococcus lactis NCDO712 reveals a novel pilus gene cluster. PLoS One 11:e0167970. doi: 10.1371/journal.pone.0167970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gasson MJ. 1983. Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol 154:1–9. doi: 10.1128/JB.154.1.1-9.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wegmann U, Overweg K, Jeanson S, Gasson M, Shearman C. 2012. Molecular characterization and structural instability of the industrially important composite metabolic plasmid pLP712. Microbiology 158:2936–2945. doi: 10.1099/mic.0.062554-0. [DOI] [PubMed] [Google Scholar]
  • 11.Oak SJ, Jha R. 2019. The effects of probiotics in lactose intolerance: a systematic review. Crit Rev Food Sci Nutr 59:1675–1683. doi: 10.1080/10408398.2018.1425977. [DOI] [PubMed] [Google Scholar]
  • 12.Grenov B, Briend A, Sangild PT, Thymann T, Rytter MH, Hother A-L, Mølgaard C, Michaelsen KF. 2016. Undernourished children and milk lactose. Food Nutr Bull 37:85–99. doi: 10.1177/0379572116629024. [DOI] [PubMed] [Google Scholar]
  • 13.Miller GD, Jarvis JK, McBean LD. 2006. Handbook of dairy foods and nutrition. CRC Press, Boca Raton, FL. [Google Scholar]
  • 14.Suchy FJ, Brannon PM, Carpenter TO, Fernandez JR, Gilsanz V, Gould JB, Hall K, Hui SL, Lupton J, Mennella J, Miller NJ, Osganian SK, Sellmeyer DE, Wolf MA. 2010. National Institutes of Health consensus development conference: lactose intolerance and health. Ann Intern Med 152:792–796. doi: 10.7326/0003-4819-152-12-201006150-00248. [DOI] [PubMed] [Google Scholar]
  • 15.Liebert A, López S, Jones BL, Montalva N, Gerbault P, Lau W, Thomas MG, Bradman N, Maniatis N, Swallow DM. 2017. World-wide distributions of lactase persistence alleles and the complex effects of recombination and selection. Hum Genet 136:1445–1453. doi: 10.1007/s00439-017-1847-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sicherer SH. 2011. Epidemiology of food allergy. J Allergy Clin Immunol 127:594–602. doi: 10.1016/j.jaci.2010.11.044. [DOI] [PubMed] [Google Scholar]
  • 17.Qamer S, Deshmukh M, Patole S. 2019. Probiotics for cow’s milk protein allergy: a systematic review of randomized controlled trials. Eur J Pediatr 178:1139–1149. doi: 10.1007/s00431-019-03397-6. [DOI] [PubMed] [Google Scholar]
  • 18.Dhama K, Latheef S, Munjal A, Khandia R, Samad H, Iqbal H, Joshi S. 2017. Probiotics in curing allergic and inflammatory conditions-research progress and futuristic vision. Recent Pat Inflamm Allergy Drug Discov 10:105–118. doi: 10.2174/1872213X10666161226162229. [DOI] [PubMed] [Google Scholar]
  • 19.He T, Priebe M, Zhong Y, Huang C, Harmsen H, Raangs G, Antoine JM, Welling G, Vonk R. 2008. Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose‐intolerant subjects. J Appl Microbiol 104:595–604. doi: 10.1111/j.1365-2672.2007.03579.x. [DOI] [PubMed] [Google Scholar]
  • 20.Valík L', Medved'ová A, Liptáková D. 2008. Characterization of the growth of Lactobacillus rhamnosus GG in milk at suboptimal temperatures. J Food Nutr Res 47:60–67. [Google Scholar]
  • 21.Samona A, Robinson R. 1994. Effect of yogurt cultures on the survival of bifidobacteria in fermented milks. Int J Dairy Technol 47:58–60. doi: 10.1111/j.1471-0307.1994.tb01273.x. [DOI] [Google Scholar]
  • 22.Ibarra A, Acha R, Calleja M-T, Chiralt-Boix A, Wittig E. 2012. Optimization and shelf life of a low-lactose yogurt with Lactobacillus rhamnosus HN001. J Dairy Sci 95:3536–3548. doi: 10.3168/jds.2011-5050. [DOI] [PubMed] [Google Scholar]
  • 23.Ceapa C, Lambert J, van Limpt K, Wels M, Smokvina T, Knol J, Kleerebezem M. 2015. Correlation of Lactobacillus rhamnosus genotypes and carbohydrate utilization signatures determined by phenotype profiling. Appl Environ Microbiol 81:5458–5470. doi: 10.1128/AEM.00851-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Douillard FP, Ribbera A, Järvinen HM, Kant R, Pietilä TE, Randazzo C, Paulin L, Laine PK, Caggia C, von Ossowski I, Reunanen J, Satokari R, Salminen S, Palva A, de Vos WM. 2013. Comparative genomic and functional analysis of Lactobacillus casei and Lactobacillus rhamnosus strains marketed as probiotics. Appl Environ Microbiol 79:1923–1933. doi: 10.1128/AEM.03467-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Heidtman MI, Merighi M, McCoy JM. June 2015. Strains of Lactobacillus rhamnosus GG capable of growth on lactose and the uses thereof. US patent 20150044330A1.
  • 26.Organisation for Economic Co-operation and Development. 2009. Directive 2009/41/EC of the European Parliament and of the Council of 6 May 2009 on the contained use of genetically modified micro-organisms. Off J Eur Union 125:75–97. [Google Scholar]
  • 27.Organisation for Economic Co-operation and Development. 2018. Commission Directive (EU) 2018/350 of 8 March 2018 amending Directive 2001/18/EC of the European Parliament and of the Council as regards the environmental risk assessment of genetically modified organisms. Off J Eur Union 67:30–45. [Google Scholar]
  • 28.Börner RA, Kandasamy V, Axelsen AM, Nielsen AT, Bosma EF. 2019. Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech. FEMS Microbiol Lett 366:i30–i41. doi: 10.1093/femsle/fny291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gasson MJ. 1990. In vivo genetic systems in lactic acid bacteria. FEMS Microbiol Rev 7:43–60. doi: 10.1111/j.1574-6968.1990.tb04878.x. [DOI] [PubMed] [Google Scholar]
  • 30.Tynkkynen S, Singh KV, Varmanen P. 1998. Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. Int J Food Microbiol 41:195–204. doi: 10.1016/s0168-1605(98)00051-8. [DOI] [PubMed] [Google Scholar]
  • 31.O'Sullivan DJ, Klaenhammer TR. 1998. Control of expression of LlaI restriction in Lactococcus lactis. Mol Microbiol 27:1009–1020. doi: 10.1046/j.1365-2958.1998.00748.x. [DOI] [PubMed] [Google Scholar]
  • 32.Barry KE, Wailan AM, Sheppard AE, Crook D, Vegesana K, Stoesser N, Parikh HI, Sebra R, Mathers AJ. 2019. Don’t overlook the little guy: an evaluation of the frequency of small plasmids co-conjugating with larger carbapenemase gene containing plasmids. Plasmid 103:1–8. doi: 10.1016/j.plasmid.2019.03.005. [DOI] [PubMed] [Google Scholar]
  • 33.Gasson MJ, Davies FL. 1980. High-frequency conjugation associated with Streptococcus lactis donor cell aggregation. J Bacteriol 143:1260–1264. doi: 10.1128/JB.143.3.1260-1264.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Frost LS, Leplae R, Summers AO, Toussaint A. 2005. Mobile genetic elements: the agents of open source evolution. Nat Rev Microbiol 3:722–732. doi: 10.1038/nrmicro1235. [DOI] [PubMed] [Google Scholar]
  • 35.Ceapa C, Davids M, Ritari J, Lambert J, Wels M, Douillard FP, Smokvina T, de Vos WM, Knol J, Kleerebezem M. 2016. The variable regions of Lactobacillus rhamnosus genomes reveal the dynamic evolution of metabolic and host-adaptation repertoires. Genome Biol Evol 8:1889–1905. doi: 10.1093/gbe/evw123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Topcuoglu S, Gursoy T, Ovali F, Serce O, Karatekin G. 2015. A new risk factor for neonatal vancomycin-resistant Enterococcus colonisation: bacterial probiotics. J Matern Fetal Neonatal Med 28:1491–1494. doi: 10.3109/14767058.2014.958462. [DOI] [PubMed] [Google Scholar]
  • 37.Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, Satokari R, Vesterlund S, Hendrickx AP, Lebeer S, de Keersmaecker SC, Vanderleyden J, Hamalainen T, Laukkanen S, Salovuori N, Ritari J, Alatalo E, Korpela R, Mattila-Sandholm T, Lassig A, Hatakka K, Kinnunen KT, Karjalainen H, Saxelin M, Laakso K, Surakka A, Palva A, Salusjarvi T, Auvinen P, de Vos WM. 2009. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Natl Acad Sci U S A 106:17193–17198. doi: 10.1073/pnas.0908876106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lebeer S, Claes I, Tytgat HLP, Verhoeven TLA, Marien E, von Ossowski I, Reunanen J, Palva A, de Vos WM, De Keersmaecker SCJ, Vanderleyden J. 2012. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 78:185–193. doi: 10.1128/AEM.06192-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gasson MJ, Swindell S, Maeda S, Dodd HM. 1992. Molecular rearrangement of lactose plasmid DNA associated with high-frequency transfer and cell aggregation in Lactococcus lactis 712. Mol Microbiol 6:3213–3223. doi: 10.1111/j.1365-2958.1992.tb01776.x. [DOI] [PubMed] [Google Scholar]
  • 40.Marugg JD, van Kranenburg R, Laverman P, Rutten G, De Vos W. 1996. Identical transcriptional control of the divergently transcribed prtP and prtM genes that are required for proteinase production in Lactococcus lactis SK11. J Bacteriol 178:1525–1531. doi: 10.1128/jb.178.6.1525-1531.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Toomey N, Monaghan Á, Fanning S, Bolton DJ. 2009. Assessment of horizontal gene transfer in lactic acid bacteria–a comparison of mating techniques with a view to optimising conjugation conditions. J Microbiol Methods 77:23–28. doi: 10.1016/j.mimet.2008.12.002. [DOI] [PubMed] [Google Scholar]
  • 42.Landete JM. 2017. A review of food-grade vectors in lactic acid bacteria: from the laboratory to their application. Crit Rev Biotechnol 37:296–308. doi: 10.3109/07388551.2016.1144044. [DOI] [PubMed] [Google Scholar]
  • 43.Thang CL, Baurhoo B, Boye JI, Simpson BK, Zhao X. 2011. Effects of Lactobacillus rhamnosus GG supplementation on cow’s milk allergy in a mouse model. Allergy Asthma Clin Immunol 7:20. doi: 10.1186/1710-1492-7-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Basturk A, Isik İ, Atalay A, Yılmaz A. 2020. Investigation of the efficacy of Lactobacillus rhamnosus GG in infants with cow’s milk protein allergy: a randomised double-blind placebo-controlled trial. Probiotics Antimicrob Proteins 12:138–143. doi: 10.1007/s12602-019-9516-1. [DOI] [PubMed] [Google Scholar]
  • 45.de Vos WM, Palva A, Palva I, Reunanen J, Von Ossowski I, Satokari R, Vesterlund S, Kankainen M, Salusjärvi T, Tynkkynen S. August 2010. Novel peptides and methods for producing them. US patent 20100196524A1.
  • 46.Ahlroos T, Tynkkynen S. 2009. Quantitative strain‐specific detection of Lactobacillus rhamnosus GG in human faecal samples by real‐time PCR. J Appl Microbiol 106:506–514. doi: 10.1111/j.1365-2672.2008.04018.x. [DOI] [PubMed] [Google Scholar]
  • 47.Anderson DG, McKay LL. 1983. Simple and rapid method for isolating large plasmid DNA from lactic streptococci. Appl Environ Microbiol 46:549–552. doi: 10.1128/AEM.46.3.549-552.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Wan X, Li R, Saris PE, Takala TM. 2013. Genetic characterisation and heterologous expression of leucocin C, a class IIa bacteriocin from Leuconostoc carnosum 4010. Appl Microbiol Biotechnol 97:3509–3518. doi: 10.1007/s00253-012-4406-4. [DOI] [PubMed] [Google Scholar]
  • 49.van den Berg DJC, Smits A, Pot B, Ledeboer AM, Kersters K, Verbake JMA, Verrips CT. 1993. Isolation, screening and identification of lactic-acid bacteria from traditional food fermentation processes and culture collections. Food Biotechnol 7:189–205. doi: 10.1080/08905439309549857. [DOI] [Google Scholar]
  • 50.Vukotic G, Mirkovic N, Jovcic B, Miljkovic M, Strahinic I, Fira D, Radulovic Z, Kojic M. 2015. Proteinase PrtP impairs lactococcin LcnB activity in Lactococcus lactis BGMN1-501: new insights into bacteriocin regulation. Front Microbiol 6:92. doi: 10.3389/fmicb.2015.00092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Zierdt CH, Swan JC. 1981. Generation time and growth-rate of the human intestinal parasite Blastocystis hominis. J Protozool 28:483–485. doi: 10.1111/j.1550-7408.1981.tb05324.x. [DOI] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES